Bio-Thera Solutions And Hikma Pharma Say FDA Approved STARJEMZA Injection

(RTTNews) - Bio-Thera Solutions Ltd and Hikma Pharmaceuticals PLC announced that the U.S. Food and Drug Administration has approved STARJEMZA (ustekinumab-hmny) Injection, a biosimilar referencing Stelara (ustekinumab) Injection. STARJEMZA is Bio-Thera's third FDA approved produc https://www.nasdaq.com/articles/bio-thera-solutions-and-hikma-pharma-say-fda-approved-starjemza-injection